Sign In
Buy LH
$258.92
+1.22 (+0.473%)
At Close: Jun 03, 2026
Labcorp to Webcast Its Annual Meeting of Shareholders
06:59am, Wednesday, 08'th May 2024
BURLINGTON, N.C. , May 8, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced that its Annual Meeting of Shareholders will be
Invitae Receives Court Approval for Sale to Labcorp
04:05pm, Tuesday, 07'th May 2024
Acquisition advances Labcorp's specialty testing strategy in key areas such as oncology and rare diseases Key milestone reached in Invitae's Chapter 11 process BURLINGTON, N.C. and SAN FRANCISCO , Ma
FDA Approves ColoSense™ – Geneoscopy's Noninvasive Multi-target Stool RNA (mt-sRNA) Colorectal Cancer Screening Test
04:00pm, Monday, 06'th May 2024
ST. LOUIS--(BUSINESS WIRE)--Geneoscopy, Inc. announced that the U.S. Food and Drug Administration (FDA) approved its noninvasive colorectal cancer screening test, ColoSense.
FDA brings lab tests under federal oversight in bid to improve accuracy and safety
07:21pm, Monday, 29'th Apr 2024
WASHINGTON — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorou
Assay expands company's leadership in precision medicine and cell and gene therapy BURLINGTON, N.C. , April 29, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensi
3 Medical Products Stocks Set to Beat This Earnings Season
12:31pm, Friday, 26'th Apr 2024
Here are three stocks, TXG, CAH and HOLX, which are expected to beat earnings estimates in the ongoing reporting cycle.
Labcorp (LH) Tops Q1 Earnings Estimates, Raises 2024 EPS View
11:20am, Thursday, 25'th Apr 2024
Labcorp (LH) sets a strong foundation for the year ahead with its impressive performance in the first quarter of 2024.
Compared to Estimates, Labcorp (LH) Q1 Earnings: A Look at Key Metrics
10:36am, Thursday, 25'th Apr 2024
Although the revenue and EPS for Labcorp (LH) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street es
Labcorp beats quarterly estimates on strong testing demand
07:09am, Thursday, 25'th Apr 2024
Labcorp beat Wall Street expectations for first-quarter profit on Thursday, as growing demand for specialty tests boosted sales at its diagnostics business.
Labcorp Announces 2024 First Quarter Results
06:58am, Thursday, 25'th Apr 2024
Updates Full-Year Guidance Results from Continuing Operations for first quarter 2024 versus last year: Revenue: $3.18 billion versus $3.04 billion or up 4.6% | Base Business grew 6.7% Diluted EPS: $2.
Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 mln
10:25pm, Wednesday, 24'th Apr 2024
Laboratory service provider Labcorp said on Wednesday it will acquire Softbank-backed Invitae Corp's assets auctioned through a voluntary bankruptcy protection process, a few months after the genetic
Labcorp Announces Winning Bid for Select Assets of Invitae
09:27pm, Wednesday, 24'th Apr 2024
Advances Labcorp strategy to launch and scale specialty testing in areas such as oncology and rare diseases Transaction requires court approval, with confirmation expected on May 6, 2024 BURLINGTON, N
Invitae Enters into Agreement with Labcorp for Sale of Business
09:19pm, Wednesday, 24'th Apr 2024
– Labcorp Selected as Winning Bidder in Court-Supervised Sale Process, Subject to Court and Regulatory Approvals – – $239 Million Cash Bid Includes Acquisition of Substantially All of the Compan
Watch These 3 MedTech Stocks This Earnings Season: Beat or Miss?
03:01pm, Wednesday, 24'th Apr 2024
Here is a sneak peek into how the three major MedTech stocks, LH, EW and RMD, are expected to fare in their quarterly results slated to be released tomorrow.
Exploring Analyst Estimates for Labcorp (LH) Q1 Earnings, Beyond Revenue and EPS
10:21am, Monday, 22'nd Apr 2024
Get a deeper insight into the potential performance of Labcorp (LH) for the quarter ended March 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some o
